Browse > Article
http://dx.doi.org/10.5392/JKCA.2017.17.07.648

Association between the Polymorphism of Glutathione S-transferase Genes and Autoimmune Diseases in Asian Population: a Meta-analysis  

Kim, Hee Sung (단국대학교 의과대학 제일병원 진단검사의학과)
Publication Information
The Journal of the Korea Contents Association / v.17, no.7, 2017 , pp. 648-663 More about this Journal
Abstract
To verify the association between GSTM1/GSTT1 gene polymorphisms and susceptibility to autoimmune diseases in Asian population. 18 published reports cited in EMBASE, Google, KISS, MEDLINE and PubMed up to December 2015 were collected for a meta-analysis. The GSTM1/GSTT1 polymorphism for null and present type were analysed separately. The significant association was found between the GST polymorphism and autoimmune diseases in an overall population (GSTM1, OR=1.334, 95% CI=1.137-1.567, p=0.000; GSTT1, OR=1.212, 95% CI=1.012-1.452, p=0.037). Asian population showed the significant association of GSTM1 in the autoimmune diseases, especially vitiligo and atopic dermatitis but non-significant association of GSTT1 in RA and SLE. The GSTM1 null and the GSTT1 present type showed the association with autoimmune diseases in Asian population. The null type frequency of the combination of GSTM1-GSTT1 polymorphism in autoimmune diseases in Asian population was higher than that of the control group. This result indicated that null type of GSTM1-GSTT1 combination can be a risk factor of autoimmune diseases in Asian population.
Keywords
Autoimmune Disease; Meta-analysis; Glutathione S-transferase; Gene Polymorphism;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Y. H. Chien, W. L. Hwu, and B. L. Chiang, "The genetics of atopic dermatitis," Clin Rev Allergy Immunol, Vol.33, pp.178-190, 2007.   DOI
2 M. Portugal, V. Barak, and I. Ginsburg, "Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations," Biomed Pharmacother, Vol.61, pp.412-422, 2007.   DOI
3 N. Omata, H. Tsukahara, and S. Ito, "Increased oxidative stress in childhood atopic dermatitis," Life Sci, Vol.69, pp.223-228, 2001.   DOI
4 L. I. Holla, A. Stejskalova, and A. Vasku, "Polymorphisms of the GSTM1 and GSTT1 genes in patients with allergic diseases in the Czech population," Allergy, Vol.61, pp.265-267, 2006.   DOI
5 J. Chung, S. Y. Oh, and Y. K. Shin, "Association of glutathione S-transferase polymorphisms with atopic dermatitis risk in preschool age children," Clin Chem Lab Med, Vol.47, pp.1475-1481, 2009.
6 I. J. Wang, Y. L. Guo, and T. J. Lin, "GSTM1, GSTP1, prenatal smoke exposure, and atopic dermatitis," Ann Allergy Asthma Immunol, Vol.105, pp.124-129, 2010.   DOI
7 W. C. de Bruin, M. J. Wagenmans, and W. H. Peters, "Expression of glutathione S-transferase alpha, P1-1 and T1-1 in the human gastrointestinal tract," Jpn J Cancer Res, Vol.91, pp.310-316, 2000.   DOI
8 Y. K. Uhm, S. H. Yoon, and I. J. Kang, "Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population," Life Sci, Vol.81, pp.223-227, 2007.   DOI
9 H. R. Cho, Y. K. Uhm, and H. J. Kim, "Glutathione S-transferase M1 (GSTM1) polymorphism is associated with atopic dermatitis susceptibility in a Korean population," Int J Immunogenet, Vol.38, pp.145-150, 2011.   DOI
10 J. Chung, S. O. Kwon, and H. Ahn, "Association between Dietary Patterns and Atopic Dermatitis in Relation to GSTM1 and GSTT1 Polymorphisms in Young Children," Nutrients, Vol.7, pp.9440-9452, 2015.   DOI
11 L. Liu, C. Li, and J. Gao, "Genetic polymorphisms of glutathione S-transferase and risk of vitiligo in the Chinese population," J Invest Dermatol, Vol.129, pp.2646-2652, 2009.   DOI
12 F. A. A. Rabou, H. Elserogy, and S. F. Gheida, "Glutathione S-Transferase Gene Polymorphisms (GSTM1 and GSTT1) in Vitiligo Patients," Life Science Journal, Vol.8, No.4, 2011.
13 D. A. Bassiouny and M. M. Khorshied, "Glutathione S-transferase M1 and T1 genetic polymorphism in Egyptian patients with nonsegmental vitiligo," Clin Exp Dermatol, Vol.38, pp.160-163, 2013.   DOI
14 B. R. Yun, A. El-Sohemy, and M. C. Cornelis, "Glutathione S-transferase M1, T1, and P1 genotypes and rheumatoid arthritis," J Rheumatol, Vol.32, pp.992-997, 2005.
15 P. Bohanec Grabar, D. Logar, and M. Tomsic, "Genetic polymorphisms of glutathione Stransferases and disease activity of rheumatoid arthritis," Clin Exp Rheumatol, Vol.27, pp.229-236, 2009.
16 A. S. Doney, S. Lee, and G. P. Leese, "Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study," Circulation, Vol.111, pp.2927-2934, 2005.   DOI
17 S. Landi, "Mammalian class theta GST and differential susceptibility to carcinogens: a review," Mut Res, Vol.463, pp.247-283, 2000.   DOI
18 I. Aguilera, I. Wichmann, and J. M. Sousa, "Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation," Clin Exp immunol, Vol.126, pp.535-539, 2001.   DOI
19 J. Seidegard, W. R. Vorachek, and R. W. Pero, "Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion," Proc Natl Acad Sci U S A, Vol.85, pp.7293-7297, 1998.
20 P. A. Fraser, W. Z. Ding, and M. Mohseni, "Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene-environment interaction for auto immunity," J Rheumatol, Vol.30, pp.276-282, 2003.
21 J. M. McCord, "Free radicals and inflammation: protection of synovial fluid by superoxide dismutase," Science (New York, N.Y.), Vol.185, pp.529-531, 1974.   DOI
22 S. Morinobu, A. Morinobu, and S. Kanagawa, "Glutathione S-transferase gene polymorphisms in Japanese patients with rheumatoid arthritis," Clin Exp Rheumatol, Vol.24, pp.268-273, 2006.
23 K. Ongenae, N. Van Geel, and J. M. Naeyaert, "Evidence for an autoimmune pathogenesis of vitiligo," Pigment Cell Res, Vol.16, pp.90-100, 2003.   DOI
24 D. L. Jacobson, S. J. Gange, and N. R. Rose, "Epidemiology and estimated population burden of selected autoimmune diseases in the United States," Clin Immunol Immunopathol, Vol.84, pp.223-243, 1997.   DOI
25 A. M. Ghelani, A. Samanta, and A. C. Jones, "Association analysis of TNFR2, VDR, A2M, GSTT1, GSTM1, and ACE genes with rheuma toid arthritis in South Asians and Caucasians of East Midlands in the United Kingdom," Rheuma tol int, Vol.31, pp.1355-1361, 2011.   DOI
26 M. M. Fernando, C. R. Stevens, and E. C. Walsh, "Defining the role of the MHC in auto immunity: a review and pooled analysis," PLoS genetics, Vol.4, p.e1000024, 2008.   DOI
27 G. G. Song, S. C. Bae, and Y. H. Lee, "The glutathione S-transferase M1 and P1 polymorphisms and rheumatoid arthritis: a meta-analysis," Mol Biol Rep, Vol.39, pp.10739-10745, 2012.   DOI
28 E. W. Karlson, S. C. Chang, and J. Cui, "Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis," Ann Rheum Dis, Vol.69, pp.54-60, 2010.   DOI
29 C. Kruger and K. U. Schallreuter, "A review of the worldwide prevalence of vitiligo in children/adolescents and adults," Int J Dermatol, Vol.51, pp.1206-1212, 2012.   DOI
30 M. Allam and H. Riad, "Concise review of recent studies in vitiligo," Qatar Med j, Vol.2013, pp.1-19, 2013.   DOI
31 S. Handa and I. Kaur, "Vitiligo: clinical findings in 1436 patients," J Dermatol, Vol.26, pp.653-657, 1999.   DOI
32 P. E. Grimes and R. Morris, "Avaniss-Aghajani E et al. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines," J Am Acad Dermatol, Vol.51, pp.52-61, 2004.   DOI
33 V. M. Sheth, Y. Guo, and A. A. Qureshi, "Comorbidities associated with vitiligo: a ten-year retrospective study," Dermatology (Basel, Switzerland ), Vol.227, pp.311-315, 2013.   DOI
34 J. G. Millichap and M. M. Yee, "The diet factor in attention-deficit/hyperactivity disorder," Pediatri cs, Vol.129, pp.330-337, 2012.   DOI
35 S. Y. Oh, J. Chung, and M. K. Kim, "Antioxidant nutrient intakes and corresponding biomarkers associated with the risk of atopic dermatitis in young children," Eur J Clin Nutr, Vol.64, pp.245-252, 2010.   DOI
36 P. D. Josephy, "Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology," Human genomics and proteomics : HGP, Vol.2010, p.876940, 2010.
37 P. J. Jakobsson, S. Thoren, and R. Morgenstern, "Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target," Proc Natl Acad Sci U S A, Vol.96, pp.7220-7225, 1999.   DOI
38 D. M. Townsend, K. D. Tew, and H. Tapiero, "The importance of glutathione in human disease," Biomed Pharmacother, Vol.57, pp.145-155, 2003.   DOI
39 P. Jemth, G. Stenberg, and G. Chaga, "Heterologous expression, purification and characterization of rat class theta glutathione transferase T2-2," Biochem J, Vol.316(Pt 1), pp.131-136, 1996.   DOI
40 Y. Rupasree, S. M. Naushad, and L. Rajasekhar, "Association of genetic variants of xenobiotic metabolic pathway with systemic lupus erythematosus," Indian J Biochem Biophys, Vol.50, pp.447-452, 2013.
41 K. Sekine, H. Mochizuki, and Y. Inoue, "Regulation of oxidative stress in patients with Kawasaki disease," Inflammation, Vol.35, pp.952-958, 2012.   DOI
42 J. Zhang, J. Deng, and C. Zhang, "Association of GSTT1, GSTM1 and CYP1A1 polymorphisms with susceptibility to systemic lupus erythematosus in the Chinese population," Clinica chimica acta; international journal of clinical chemistry, Vol.411, pp.878-881, 2010.   DOI
43 R. J. Hung, P. Boffetta, and J. Brockmoller, "CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers : a pooled analysis," Carcinogenesis, Vol.24, pp.875-882, 2003.   DOI
44 B. Mannervik, Y. C. Awasthi, and P. G. Board, "Nomenclature for human glutathione transferases," Biochem J, Vol.282(Pt 1), pp.305-306, 1992.   DOI
45 T. Horiuchi, M. Washio, and C. Kiyohara, "Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk of Japanese SLE: findings from the KYSS study," Rheumatology (Oxford, England), Vol.48, pp.1045-1049, 2009.   DOI
46 T. Kato, H. Miyakawa, and M. Ishibashi, "Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis," J Autoimmun, Vol.22, pp.211-216, 2004.   DOI
47 R. D. Mittal, P. K. Manchanda, and H. K. Bid, "Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India," J Gastro enterol Hepatol, Vol.22, pp.920-924, 2007.   DOI
48 B. Ardesjo, C. M. Hansson, and C. E. Bruder, "Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases," J Autoimmun, Vol.30, pp.273-282, 2008.   DOI
49 B. T. Ashok and R. Ali, "Binding of human anti-DNA autoantibodies to reactive oxygen species modified-DNA and probing oxidative DNA damage in cancer using monoclonal antibody," International journal of cancer, Vol.78, pp.404-409, 1998.   DOI
50 B. T. Ashok and R. Ali, "The aging paradox: free radical theory of aging," Exp Gerontol, Vol.34, pp.293-303, 1999.   DOI
51 J. D. Ji and W. J. Lee, "Association between the polymorphisms of glutathione S-transferase genes and rheumatoid arthritis: a meta-analysis," Gene, Vol.521, pp.155-159, 2013.   DOI
52 Y. K. Uhm, S. H. Yoon, and I. J. Kang, "Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population," Life Sciences, Vol.81, pp.223-227, 2007.   DOI
53 A. Wandstrat and E. Wakeland, "The genetics of complex autoimmune diseases: non-MHC susceptibility genes," Nat Immunol, Vol.2, pp.802-809, 2001.   DOI
54 K. G. Becker, "Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?," Diabetes, Vol.48, pp.1353-1358, 1999.   DOI
55 W. Maidhof and O. Hilas, "Lupus: an overview of the disease and management options." P & T, Vol.37, pp.240-249, 2012.
56 G. J. Pons-Estel, G. S. Alarcon, and L. Scofield, "Understanding the epidemiology and progress ion of systemic lupus erythematosus," Seminars in arthritis and rheumatism, Vol.39, pp.257-268, 2010.   DOI
57 G. C. Tsokos, "Systemic lupus erythematosus," The N Engl j Med, Vol.365, pp.2110-2121, 2011.   DOI
58 R. Gualtierotti, M. Biggioggero, and A. E. Penatti, "Updating on the pathogenesis of systemic lupus erythematosus," Autoimmun rev, Vol.10, pp.3-7, 2010.   DOI
59 G. S. Firestein, "Evolving concepts of rheumatoid arthritis," Nature, Vol.423, pp.356-361, 2003.   DOI
60 D. M. Lee and M. E. Weinblatt, "Rheumatoid arthritis," Lancet, Vol.358, pp.903-911, 2001.   DOI
61 D. L. Scott, F. Wolfe, and T. W. Huizinga, "Rheumatoid arthritis," Lancet, Vol.376, pp.1094-1108, 2010.   DOI
62 G. Orozco, S. Eyre, and A. Hinks, "Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study," Ann Rheum Dis, Vol.69, pp.813-816, 2010.   DOI
63 S. Morinobu, A. Morinobu, and S. Kanagawa, "Glutathione S-transferase gene polymorphisms in Japanese patients with rheumatoid arthritis," Clin Exp Rheumatol, Vol.24, pp.268-273, 2006.
64 A. M. Ghelani, A. Samanta, and A. C. Jones, "Association analysis of TNFR2, VDR, A2M, GSTT1, GSTM1, and ACE genes with rheumatoid arthritis in South Asians and Caucasians of East Midlands in the United Kingdom," Rheumatol Int, Vol.31, pp.1355-1361, 2011.   DOI
65 M. Hashemi, "A Possible Relationship Between Polymorphisms of Glutathione S-Transferase M1, P1 and T1 Genes and Rheumatoid Arthritis in Zahedan, Southeast Iran," Turkish Journal of Rheumatology, pp.253-257, 2012.
66 H. Jiang, S. Wang, and G. Luo, "Relationship between the glutathione S-transferase class ${\mu}$ ($GST{\mu}$) gene deletion, oxidative injury and systemic lupus erythematosus," Chin J Rheumatol, Vol.5, pp.156-159, 2001.
67 L. F. Eichenfield, W. L. Tom, and T. G. Berger, "Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies," J Am Acad Dermatol, Vol.71, pp.116-132, 2014.   DOI
68 H. S. Ozturk, M. Y. Cimen, and O. B. Cimen, "Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis," Rheumatol Int, Vol.19, pp.35-37, 1999.   DOI
69 A. D. Ross, N. K. Banda, and M. Muggli, "Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular super oxide dismutase," Arthritis Rheum, Vol.50, pp.3702-3711, 2004.   DOI
70 H. R. Griffiths, "Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?," Autoimm Rev, Vol.7, pp.544-549, 2008.   DOI
71 T. Bieber, "Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine," Allergy, Vol.67, pp.1475-1482, 2012.
72 H. Tsukahara, R. Shibata, and Y. Ohshima, "Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis," Life Sci, Vol.72, pp.2509-2516, 2003.   DOI
73 G. K. Ching, K. L. Hon, and P. C. Ng, "Filaggrin null mutations in childhood atopic dermatitis among the Chinese," Int J Immuno genet, Vol.36, pp.251-254, 2009.   DOI
74 S. Weidinger, N. Klopp, and S. Wagenpfeil, "Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults," J Med Genet, Vol.41, pp.658-663, 2004.   DOI
75 S. Weidinger, E. Rodriguez, and C. Stahl, "Filaggr in mutations strongly predispose to early-onset and extrinsic atopic dermatitis," J Invest Derma tol, Vol.127, pp.724-726, 2007.   DOI
76 C. Kiyohara, M. Washio, and T. Horiuchi, "Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population," Scand J Rheumatol, Vol.41, pp.103-109, 2012.   DOI
77 T. Y. Kang, A. El-Sohemy, and M. C. Comelis, "Glutathione S-transferase genotype and risk of systemic lupus erythematosus in Koreans," Lupus, Vol.14, pp.381-384, 2005.   DOI
78 T. Horiuchi, M. Washio, and C. Kiyohara, "Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk of Japanese SLE: findings from the KYSS study," Rheumatology (Oxford), Vol.48, pp.1045-1049, 2009.   DOI
79 J. Zhang, J. Deng, and C. Zhang, "Association of GSTT1, GSTM1 and CYP1A1 polymorphisms with susceptibility to systemic lupus erythematosus in the Chinese population," Clin Chim Acta, Vol.411, pp.878-881, 2010.   DOI
80 T. R. Mikuls, T. Levan, and K. A. Gould, "Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans," Arthritis Rheum, Vol.64, pp.655-664, 2012.   DOI
81 C. Carlsten, G. S. Sagoo, and A. J. Frodsham, "Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis," Am J Epidemiol, Vol.167, pp.759-774, 2008.   DOI
82 L. A. Criswell, L. A. Merlino, and J. R. Cerhan, "Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study," Am J Med, Vol.112, pp.465-471, 2002.   DOI
83 L. Lu, W. Wu, and Y. Tu, "Association of glutathione S-transferase M1/T1 polymorphisms with susceptibility to vitiligo," Gene, Vol.535, pp.12-16, 2014.   DOI
84 L. Liu, C. Li, and J. Gao, "Genetic polymorphisms of glutathione S-transferase and risk of vitiligo in the Chinese population," J Invest Dermatol, Vol.129, pp.2646-2652, 2009.   DOI
85 F. Guarneri, A. Asmundo and D. Sapienza, "Glutathione S-transferase M1/ T1 gene polymorphisms and vitiligo in a Mediterranean population," Pigment cell & melanoma research, Vol.24, pp.731-733, 2011.   DOI